Money Following Trust: Evidence from China’s High‐Value Payment System
International Review of Finance · 2019-06 · 19 (2) · 385-412
DOI: 10.1111/irfi.12184 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Review of Finance, online erschienen am 29.01.2018. Verfasst von Xianhang Qian und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Shandong Province, Central University of Finance and Economics, Shandong University.
Abstract (Originalsprache)
This study enriches the economic consequence of trust from the perspective of cash flow. It analyzes the impact of trust on interprovincial cash flow using matching data pertaining to Chinese provincial trust and the high‐value payment system in 2006–2010. It further investigates trust’s effect in different legal protection scenarios to explore the interactive role of formal and informal institutions. The results indicate that trust can significantly promote interprovincial cash flow and it persists after addressing endogeneity concerns and across different methods. However, this effect is only significant or much larger in provinces with less legal protection, indicating the alternative roles played by trust and formal institutions.
Förderung
- Shandong Province
- Central University of Finance and Economics
- Shandong University
Zitieren
APA
Qian, X., Zhang, G., & Cao, T. (2019). Money Following Trust: Evidence from China’s High‐Value Payment System. International Review of Finance, 19(2), 385-412. https://doi.org/10.1111/irfi.12184
Vancouver
Qian X, Zhang G, Cao T. Money Following Trust: Evidence from China’s High‐Value Payment System. International Review of Finance. 2019;19(2):385-412. doi:10.1111/irfi.12184
BibTeX
@article{Qian2019,
author = {Qian, Xianhang and Zhang, Guangli and Cao, Tingqiu},
title = {Money Following Trust: Evidence from China’s High‐Value Payment System},
journal = {International Review of Finance},
year = {2019},
volume = {19},
number = {2},
pages = {385--412},
doi = {10.1111/irfi.12184}
}
EUVIMED